Copertina

A randomized sequential cross‐over trial evaluating five purportedly ICP ‐lowering drugs in idiopathic intracranial hypertension

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	James L. Mitchell, Hannah S. Lyons, Jessica K. Walker, Andreas Yiangou, Mark Thaller, Olivia Grech, Zerin Alimajstorovic, Georgios Tsermoulas, Kristian Brock, Susan P. Mollan, Alexandra J. Sinclair
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Headache: The Journal of Head and Face Pain
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Arachnoid granulations in idiopathic intracranial hypertension: Do they have an influence?
di: Arndt‐Hendrik Schievelkamp, et al.
Pubblicazione: (2024)

In reply to: “Glymphatic dysfunction is unlikely to cause idiopathic intracranial hypertension”
di: Derrek Schartz, et al.
Pubblicazione: (2026)

Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies
di: Irina Krikova, et al.
Pubblicazione: (2024)

A unifying disease model of idiopathic intracranial hypertension: A narrative review
di: Derrek Schartz, et al.
Pubblicazione: (2025)

Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review
di: Marina Romozzi, et al.
Pubblicazione: (2025)

Baseline factors associated with post‐stenting intracranial pressure in patients with idiopathic intracranial hypertension with venous sinus stenosis
di: Shuang Song, et al.
Pubblicazione: (2025)

Role of diffusion tensor imaging in the evaluation of white matter integrity in idiopathic intracranial hypertension
di: Bahar Atasoy, et al.
Pubblicazione: (2024)

Impact of Ramadan fasting on vision and headache‐related quality of life in women with idiopathic intracranial hypertension: A prospective observational study
di: Mona Hussein, et al.
Pubblicazione: (2024)

Is headache always necessary for the diagnosis of rebound intracranial hypertension in patients successfully treated for cerebrospinal fluid venous fistula?
di: Rayyan Kinsara, et al.
Pubblicazione: (2026)

Genetically proxied liability to migraine and risk of intracranial aneurysm and subarachnoid hemorrhage
di: Iyas Daghlas, et al.
Pubblicazione: (2024)

Lateral ventricular choroid plexus enlargement in patients with spontaneous intracranial hypotension
di: Sojung Yoon, et al.
Pubblicazione: (2025)

Quantitative analysis of thecal sac volume and morphology as a diagnostic tool in intracranial hypotension
di: Kerry Knievel, et al.
Pubblicazione: (2025)

Evaluation of white matter integrity by using diffusion tensor imaging in spontaneous intracranial hypotension
di: Serdar Balsak, et al.
Pubblicazione: (2025)

Factors to predict recurrence after epidural blood patch in patients with spontaneous intracranial hypotension
di: Seung Hyun Lee, et al.
Pubblicazione: (2024)

Sex differences in the clinical manifestations and treatment outcomes in a large cohort of spontaneous intracranial hypotension
di: Po‐Tso Lin, et al.
Pubblicazione: (2024)

Phenotype of midfacial pain in 12 new cases—A multidisciplinary idiopathic facial pain syndrome
di: Marcin Straburzyński, et al.
Pubblicazione: (2025)

Mild cognitive impairment in spontaneous intracranial hypotension and its rapid reversal by repair of a spinal cerebrospinal fluid leak
di: Katharina Wolf, et al.
Pubblicazione: (2024)

Patients with chronic post‐dural puncture headache do not have typical imaging features of intracranial hypotension: An MRI study using the Bern score
di: Charlotte Zander, et al.
Pubblicazione: (2025)

Patterns of clinical and imaging presentations in patients with spontaneous intracranial hypotension due to spinal cerebrospinal fluid venous fistula: A single‐center retrospective cross‐sectional study
di: Andrew L. Callen, et al.
Pubblicazione: (2024)

Intracranial hypertension with papilledema associated with long‐term use of over‐the‐counter retinol day cream
di: Matthieu Batens, et al.
Pubblicazione: (2025)

Arterial hypertension: A safety risk of calcitonin gene‐related peptide ligand and receptor blocker class
di: David Croteau, et al.
Pubblicazione: (2026)

Assessing blood pressure changes and hypertension‐related outcomes in patients with migraine treated with erenumab: A systematic review and meta‐analysis
di: Luana Miyahira Makita, et al.
Pubblicazione: (2025)

Do antithrombotic drugs have a role in migraine prevention? A systematic review
di: Federico De Santis, et al.
Pubblicazione: (2025)

The impact of the migraine treatment onabotulinumtoxinA on inflammatory and pain responses: Insights from an animal model
di: Philip Victor Reducha, et al.
Pubblicazione: (2024)

Potential drug interaction between calcitonin gene‐related peptide antagonists and neonatal Fc receptor inhibitors
di: Alex Harlan, et al.
Pubblicazione: (2025)

Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
di: Gabriel Camargo de Oliveira, et al.
Pubblicazione: (2026)

Magnetoencephalography studies in migraine and headache disorders: A systematic review
di: Raghavan Gopalakrishnan, et al.
Pubblicazione: (2024)

TRPM3 activation causes CGRP release in trigeminal neurons: Implications for migraine mechanisms
di: Philip V. Reducha, et al.
Pubblicazione: (2025)

Gepants for headache prevention in children and adolescents: A multicenter chart review study
di: Lauren Shin, et al.
Pubblicazione: (2025)

CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity
di: Martin K. Madsen, et al.
Pubblicazione: (2024)

Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study
di: Maggie R. Mittleman, et al.
Pubblicazione: (2024)

Sex‐specific differences in the relationship between AHA Life's Essential 8 factors and migraine disorders: A cross‐sectional evaluation in ELSA ‐Brasil study
di: Arão Belitardo de Oliveira, et al.
Pubblicazione: (2025)

Case report: Treatment of temporomandibular joint disorder pain with V3 nerve block procedure
di: Dean Zeldich, et al.
Pubblicazione: (2025)

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
di: Jessica Ailani, et al.
Pubblicazione: (2024)

Welcoming Headache 's 2024 incoming class of Assistant Editors
di: Sarah M. Bobker
Pubblicazione: (2024)

A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study
di: Jeffrey D. Sharon, et al.
Pubblicazione: (2024)

Efficacy of an educational website on headaches in schoolchildren: A cluster‐randomized controlled trial
di: Henrike Goldstein, et al.
Pubblicazione: (2025)

Heightened migraine risk in patients with rheumatoid arthritis: A national retrospective cohort study
di: Seonyoung Kang, et al.
Pubblicazione: (2024)

Comfort matters: A new strategy to ease injection pain during headache treatment procedures
di: Hannah F. J. Shapiro
Pubblicazione: (2026)

IV dexamethasone as adjuvant therapy to metoclopramide for acute posttraumatic headache in the ED : A randomized controlled trial
di: Kareem Joudi, et al.
Pubblicazione: (2026)